Jonathan N. King - Concepedia

Author

Jonathan N. King

Also Known As

J N King, J. King, J. N. KING, J. N. King, J. N.KING, J.N. KING, J.N. King, Jonathan King, Jonathan N King, Jonathan N. KING

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Royal Veterinary College Elanco (United States)École Nationale Vétérinaire de Toulouse Novartis (France)

About

Jonathan N. King is an author at Novartis (Switzerland) specializing in medicine, veterinary science, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	25	1.3K
2	Health Sciences	3	3	102
3	Education	2	2	235
4	Natural Sciences	1	1	61
5	Public Health	1	1	10

Jonathan N. King

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Factors in Cats with Chronic Kidney Disease Jonathan N. King, Séverine Tasker, Danièlle Gunn‐Moore, Journal of Veterinary Internal Medicine	2007	183
Treatment of separation anxiety in dogs with clomipramine: results from a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial Jonathan N. King, Barbara S. Simpson, Karen L. Overall, Applied Animal Behaviour Science AnesthesiaPsychiatrySmall Animal Internal MedicinePsychopharmacologySeparation Anxiety	2000	181
Detection of endotoxin in cases of equine colic Jonathan N. King, E. Gerring Veterinary Record GastroenterologyPathologyEducationVeterinary ResearchVeterinary Microbiology	1988	141
Tolerability and Efficacy of Benazepril in Cats with Chronic Kidney Disease Jonathan N. King, Danièlle Gunn‐Moore, Séverine Tasker, Journal of Veterinary Internal Medicine Animal PhysiologyRenal Survival TimeHypertensionRenal FunctionKidney Failure	2006	98
The action of low dose endotoxin on equine bowel motility Jonathan N. King, E. L. GERRING Equine Veterinary Journal GastroenterologyPathologyEducationVeterinary ResearchSurgery	1991	94
Antagonism of endotoxin‐induced disruption of equine bowel motility by flunixin and phenylbutazone Jonathan N. King, E. L. GERRING Equine Veterinary Journal	1989	90
Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase‐2 Jonathan N. King, Janet Dawson, Ronald E. Esser, Journal of Veterinary Pharmacology and Therapeutics Pge2 ProductionImmunologyCellular PharmacologyPharmacotherapyOxidative Stress	2009	76
Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases Mike W. Martin, M. J. Stafford Johnson, G. Strehlau, Journal of Small Animal Practice	2010	70
Clinical safety of robenacoxib in feline osteoarthritis: results of a randomized, blinded, placebo-controlled clinical trial Jonathan N. King, Stephen King, Steven C. Budsberg, Journal of Feline Medicine and Surgery	2015	68
Analytical determination and pharmacokinetics of robenacoxib in the dog Martin Jung, P. Lees, Wolfgang Seewald, Journal of Veterinary Pharmacology and Therapeutics Pharmacological StudyAnti-inflammatory Drug RobenacoxibAnalytical MethodMedicineTerminal Half-life	2009	63

Page 1